General Information
edit

Website	aragonpharmaceuti...
Category	BioTech
Email
Employees
Description	Hormone-resistant Cancer Treatment

Offices
edit

Funding
edit

Series A, 5/09
The Column Group
OrbiMed Advisors

$8M

Tags
edit

cancer, prostate, therapeutics, discovery-stage, biopharmaceutical, hormone-resistant

Aragon Pharmaceuticals
edit

Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.

Milestones
edit

Aragon Pharmaceuticals received $8M in Series A funding. (5/27/09)

Posted 6/17/09 at 1:23pm

Videos

Screenshots
edit

Above: Aragon0609
Uploaded: 6/17/09

Sources

Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]

Edit This Page
Last Edited 6/17/09

Revision History

Recent Incoming Links

Exalead: Redefining Information...

exalead.com

External Links

edit

Embed Widget

CrunchBase API

JSON Representation of this page.
More API docs »

General Information edit

Offices edit

Funding edit

Tags edit

Aragon Pharmaceuticals edit

Milestones edit